Richard Lehman, BM, BCh, MRCGP

All posts by Richard Lehman, BM, BCh, MRCGP

January 29th, 2013

Selections from Richard Lehman’s Literature Review: January 28th

This week’s topics include using hospital readmission as a quality marker and the cardiovascular safety of peginesatide for anemia in patients with CKD.


January 21st, 2013

Selections from Richard Lehman’s Literature Review: January 21st

This week’s topics include a review of drug-eluting stents and a summary of hypertrophic cardiomyopathy.


January 14th, 2013

Selections from Richard Lehman’s Literature Review: January 14th

This week’s topic is egg consumption and the risk of CHD and stroke.


January 7th, 2013

Selections from Richard Lehman’s Literature Review: January 7th

This week’s topics include a study of survival among patients receiving a primary prevention ICD in clinical practice vs. clinical trials and the RELAX-AHF trial, which examined treatment of acute HF with serelaxin.


December 27th, 2012

Selections from Richard Lehman’s Literature Review: December 27th

This week’s topics include an intensive lifestyle intervention and its association with type-2 diabetes remission, strategies for multivessel revascularization in patients with diabetes, and more.


December 17th, 2012

Selections from Richard Lehman’s Literature Review: December 17th

This week’s topics include a study on ICD programming to reduce inappropriate therapy and mortality, a clinical review of diagnosing and managing supraventricular tachycardia, the Global Burden of Disease Study 2010, and more.


December 10th, 2012

Selections from Richard Lehman’s Literature Review: December 10th

This week’s topics include a comparison of warfarin and new oral anticoagulants for managing AF and VTE, two studies of a monoclonal antibody to PCSK9 in patients with hypercholesterolemia, and more.


December 3rd, 2012

Selections from Richard Lehman’s Literature Review: December 3rd

This week’s topics include the association between aldosterone-antagonist therapy and mortality and readmission among patients with HF and reduced EF, warfarin therapy after bioprosthetic AVR, and more.


November 29th, 2012

European Medicines Agency Destroys the Dam: Slight Dampness Results

Richard Lehman recounts an EMA data transparency workshop during which ideas for how to execute its new policy of allowing access to all data submitted for drug licensing were discussed.


November 26th, 2012

Selections from Richard Lehman’s Literature Review: November 26th

This week’s topics include fish oil and postoperative AF, low-dose aspirin for preventing recurrent VTE, a long-term comparison of endovascular and open repair of abdominal aortic aneurysm, and more.